Concepedia

Konstantin Glazomitsky

KG

Statistics

Publications

5

Citations

194

H-Index

5

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Konstantin Glazomitsky is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biotechnology, life sciences, and protein engineering.

Publications per year

1991–1996

5

Publications

5

Monoclonal Antibody Process Development Using Medium Concentrates

Theodora A. Bibila, Colette S. Ranucci, Konstantin Glazomitsky et al. · Biotechnology Progress · 1994 · 92 citations

, , +17

Restricticin, a novel glycine-containing antifungal agent.

Robert E. Schwartz, Claude Dufresne, James E. Flor et al. · The Journal of Antibiotics · 1991 · 43 citations · Full text

, , +9

Optimization of a Fed‐batch Process for Production of a Recombinant Antibody

David K. Robinson, T. Craig Seamans, Sandra L. Gould et al. · Annals of the New York Academy of Sciences · 1994 · 25 citations

, , +14

Large scale production of recombinant mouse and rat growth hormone by fed-batch GS-NSO cell cultures

Weichang Zhou, Theodora A. Bibila, Konstantin Glazomitsky et al. · Cytotechnology · 1996 · 20 citations

, , +15

Investigation of NS0 Cell Metabolic Behavior in Monoclonal Antibody Producing Clones

Theodora A. Bibila, Colette S. Ranucci, Konstantin Glazomitsky et al. · Annals of the New York Academy of Sciences · 1994 · 14 citations

, , +6

1–5 of 5